Bloomberg news has an article on this,,starts with monitoring health info and determining cost effective treatments as allowable. Discouraging experimentaltreatments. Would affect cancer treatment which is now sort of a stable disease for some with longer survival. That might be disallowed. This has great ramifications for older people as well as anyone with chronic disease.
It has penalties for non-compliance